A few excerpts from your linked site indicates how thorough the company should be about what they release regarding results, implying a time constraint of more than a few days (at least!) before one should expect results to be made publicly available. Still, of course they intend to release trial data when they have done the DD that they believe is required.
[quoteDetermining what to say, however, requires great nuance to ensure that meaningful information is relayed while clearly describing the limits of the company’s knowledge.
...
Life sciences companies should have protocols in place to ensure that all statements about significant developments in clinical trials and the regulatory approval process are carefully reviewed for accuracy. It may be prudent for such statements to be reviewed by an interdisciplinary team that includes members of the company’s senior executive leadership, investor relations, scientific experts, regulatory experts, in-house counsel and, where appropriate outside counsel with expertise in both securities and FDA law.[/quote]
News 
Market Data 
Discover 
